Seminars in Nuclear Medicine
Volume 39, Issue 1 , Pages 52-65 , January 2009

Nuclear Medicine and Diabetic Foot Infections

  • Christopher J. Palestro, MD

      Affiliations

    • Department of Nuclear Medicine and Radiology, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY
    • Division of Nuclear Medicine and Molecular Imaging, North Shore Long Island Jewish Health System, New Hyde Park, NY
    • Corresponding Author InformationAddress reprint requests to Christopher J. Palestro, MD, Division of Nuclear Medicine and Molecular Imaging, Long Island Jewish Medical Center, 270-05 76th Avenue, New Hyde Park, NY 11040
    • ,
  • Charito Love, MD

      Affiliations

    • Department of Nuclear Medicine and Radiology, Albert Einstein College of Medicine of Yeshiva University, Bronx, NY

References 

  1. Anderson CA, Roukis TS. The diabetic foot. Surg Clin N Am. 2007;87:1149–1177
  2. Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers: A clinical sign of underlying osteomyelitis in osteomyelitis. J Am Med Assoc. 1995;273:721–723
  3. Lavery LA, Armstrong DG, Peters EJG, et al. Probe-to-bone test for diagnosing diabetic foot osteomyelitis (Reliable or relic?). Diabetes Care. 2007;30:270–274
  4. Palestro CJ, Love C, Miller TT. Imaging of musculoskeletal infections. Best Pract Res Clin Rheumatol. 2006;20:1197–1218
  5. Palestro CJ, Love C. Radionuclide imaging of musculoskeletal infection: Conventional agents. Semin Musculoskeletal Radiol. 2007;11:335–352
  6. Keenan AM, Tindel NL, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques. Arch Intern Med. 1989;149:2262–2266
  7. Larcos G, Brown ML, Sutton R. Diagnosis of osteomyelitis of the foot in diabetic patients: Value of 111In-leukocyte scintigraphy. AJR Am J Roentgenol. 1991;157:527–531
  8. Maurer AH, Millmond SH, Knight LC, et al. Infection in diabetic osteoarthropathy: Use of indium-labeled leukocytes for diagnosis. Radiology. 1986;151:221–225
  9. Johnson JE, Kennedy EJ, Shereff MJ, et al. Prospective study of bone, indium-111-labeled white blood cell, and gallium-67 scanning for the evaluation of osteomyelitis in the diabetic foot. Foot Ankle Int. 1996;17:10–16
  10. Devillers A, Moissan A, Hennion F, et al. Contribution of technetium-99m hexamethylpropylene amine oxime labeled leucocyte scintigraphy to the diagnosis of diabetic foot infection. Eur J Nucl Med. 1998;25:132–138
  11. Harvey J, Cohen MM. Technetium-99-labeled leukocytes in diagnosing diabetic osteomyelitis in the foot. J Foot Ankle Surg. 1997;36:209–214
  12. Blume PA, Dey HM, Dailey LJ, et al. Diagnosis of pedal osteomyelitis with Tc-99m HMPAO labeled leukocytes. J Foot Ankle Surg. 1997;36:120–126
  13. Palestro CJ, Caprioli R, Love C, et al. Rapid diagnosis of pedal osteomyelitis in diabetics with a technetium-99m labeled monoclonal antigranulocyte antibody. J Foot Ankle Surg. 2003;42:2–8
  14. Seldin DW, Heiken J, Feldman F, et al. Effect of soft tissue pathology on detection of pedal osteomyelitis in diabetics. J Nucl Med. 1985;26:988–993
  15. Newman LG, Waller J, Palestro CJ, et al. Unsuspected osteomyelitis in diabetic foot ulcers (Diagnosis and monitoring by leukocyte scanning with indium In111 oxyquinoline). J Am Med Assoc. 1991;266:1246–1251
  16. Alazraki N, Dries D, Datz F, et al. Value of a 24-hour image (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease. J Nucl Med. 1985;26:711–717
  17. Israel O, Gips S, Jerushalmi J, et al. Osteomyelitis and soft-tissue infection: Differential diagnosis with 24 hour/4 hour ratio of Tc-99m MDP uptake. Radiology. 1987;163:725–726
  18. Schauwecker DS, Park HM, Burt RW, et al. Combined bone scintigraphy and indium-111 leukocyte scans in neuropathic foot disease. J Nucl Med. 1988;29:1651–1655
  19. Poirier JY, Garin E, Derrien C, et al. Diagnosis of osteomyelitis in the diabetic foot with 99mTc-HMPAO leukocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy. Diabetes Metab. 2002;28:485–490
  20. Palestro CJ, Tomas MB. Scintigraphic evaluation of the diabetic foot. In:  Freeman LM editors. Nuclear Medicine Annual 2000. Philadelphia: Lippincott Williams & Wilkins; 2000;pp 143-172
  21. Palestro CJ, Mehta HH, Patel M, et al. Marrow versus infection in the Charcot joint: Indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy. J Nucl Med. 1998;39:346–350
  22. Seabold JE, Flickinger FW, Kao SC, et al. Indium-111-leukocyte/technetium-99m-MDP bone and magnetic resonance imaging: Difficulty of diagnosing osteomyelitis in patients with neuropathic osteoarthropathy. J Nucl Med. 1990;31:549–556
  23. Gandsman EJ, Deutsch SD, Kahn CB, et al. Differentiation of Charcot joint from osteomyelitis through dynamic bone imaging. Nucl Med Commun. 1990;11:45–53
  24. Love C, Palestro CJ. Radionuclide imaging of infection. J Nucl Med Tech. 2004;32:47–57
  25. Dominguez-Gadea L, Martin-Curto LM, de la Calle H, et al. Diabetic foot infections: Scintigraphic evaluation with 99Tcm-labelled anti-granulocyte antibodies. Nucl Med Commun. 1993;14:212–218
  26. Love C, Palestro CJ. 99mTc-fanolesomab. IDrugs. 2003;6:1079–1085
  27. Harwood SJ, Valdivia S, Hung GL, et al. Use of sulesomab, a radiolabeled antibody fragment, to detect osteomyelitis in diabetic patients with foot ulcers by leukoscintigraphy. Clin Infect Dis. 1999;28:1200–1205
  28. Delcourt A, Huglo D, Prangere T, et al. Comparison between Leukoscan® (Sulesomab) and gallium-67 for the diagnosis of osteomyelitis in the diabetic foot. Diabetes Metab. 2005;31:125–133
  29. Sonmezoglu K, Sonmezoglu M, Halac M, et al. Usefulness of 99mTc-ciprofloxacin (Infecton) scan in diagnosis of chronic orthopedic infections: Comparative study with 99mTc-HMPAO leukocyte scintigraphy. J Nucl Med. 2001;42:567–574
  30. de Winter F, Gemmel F, Van Laere K, et al. 99mTc-ciprofloxacin planar and tomographic imaging for the diagnosis of infection in the postoperative spine: experience in 48 patients. Eur J Nucl Med Mol Imaging. 2004;31:233–239
  31. Gemmel F, de Winter F, Van Laere K, et al. 99mTc ciprofloxacin imaging for the diagnosis of infection in the postoperative spine. Nucl Med Commun. 2004;25:277–283
  32. Sarda L, Saleh-Mghir A, Peker C, et al. Evaluation of (99m)Tc-ciprofloxacin scintigraphy in a rabbit model of Staphylococcus aureus prosthetic joint infection. J Nucl Med. 2004;43:239–245
  33. Palestro CJ, Love C, Caprioli R, et al. Phase II study of 99mTc-ciprofloxacin uptake in patients with high suspicion of osteomyelitis. Presented at the 2006 SNM Meeting, San Diego, CA, June 3-7 2006;
  34. Oyen WJG, Paetrick M, Netten J, et al. Evaluation of infectious diabetic foot complications with indium-111-labeled human nonspecific immunoglobulin G. J Nucl Med. 1992;33:1330–1336
  35. Remedios D, Valabhji J, Oelbaum R, et al. 99mTc-nanocolloid scintigraphy for assessing osteomyelitis in diabetic neuropathic feet. Clin Radiol. 1998;53:120–125
  36. Bar-Shalom R, Yefremov N, Guralnik L, et al. SPECT/CT using 67Ga and 111In-labeled leukocyte scintigraphy for diagnosis of infection. J Nucl Med. 2006;47:587–594
  37. Filippi L, Schillaci O. Tc-99m HMPAO-labeled leukocyte scintigraphy for bone and joint infections. J Nucl Med. 2006;47:1908–1913
  38. Horger M, Eschmann SM, Pfannenberg C, et al. The value of SPET/CT in chronic osteomyelitis. Eur J Nucl Med Mol Imaging. 2003;30:1665–1673
  39. Horger M, Eschmann SM, Pfannenberg C, et al. Added value of SPECT/CT in patients suspected of having bone infection: Preliminary results. Arch Orthop Trauma Surg. 2007;127:211–221
  40. Keidar Z, Militianu D, Melamed E, et al. The diabetic foot: initial experience with 18F-FDG-PET/CT. J Nucl Med. 2005;46:444–449
  41. Schwegler B, Stumpe KD, Weishaupt D, et al. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB. J Intern Med. 2008;263:99–106
  42. Basu S, Chryssikos T, Houseni M, et al. Potential role of FDG-PET in the setting of diabetic neuro-osteoarthropathy: Can it differentiate uncomplicated Charcot's neuropathy from osteomyelitis and soft tissue infection?. Nucl Med Commun. 2007;28:465–472
  43. Hopfner S, Krolak C, Kessler S, et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: Comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int. 2004;25:890–895
  44. Jay PR, Michelson JD, Mizel MS, et al. Efficacy of three-phase bone scan in evaluating diabetic foot ulcers. Foot Ankle Int. 1999;20:347–355
  45. Love C, Tomas M, Palestro CJ. Labeled leukocyte imaging for diagnosing diabetic pedal osteomyelitis: 99mTc-exametazime vs. 111In-oxine. Presented at the Annual Meeting of the European Association of Nuclear Medicine, Munich, Germany, October 11-15 2008;

PII: S0001-2998(08)00103-7

doi: 10.1053/j.semnuclmed.2008.08.006

Seminars in Nuclear Medicine
Volume 39, Issue 1 , Pages 52-65 , January 2009

Article Tools

* Image Usage & Resolution